2009-12-01 During 2009 further vaccine trials have been finalised and analysed with positive results. We have in these tests reduced the fusion proteins from seven to three. This indicates that the production co...
2009-12-01 Gladly the issue of 500.000 new shares of series B corresponding to 1.8 MSEK was substantially oversubscribed. For those wishing more than one block of shares (1000 shares) the number of blocks allo...
2009-06-16
...
2009-06-16
...
2009-06-10 Intervacc develops recombinant vaccines, the new generation of vaccines resulting from recent progress in microbiology and gene technology. The genome of Streptococcus equi has been sequenced. This ha...
2009-06-09
Resultaten från testerna på måldjuret, häst, i England har varit mycket lovande
Intervaccs vaccinstudier på häst
To develop vaccines for the horse, it is necessary to do experimenta...